Related references
Note: Only part of the references are listed.Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells
Munevver Yenigul et al.
MOLECULAR BIOLOGY REPORTS (2022)
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
Hu Lei et al.
NATURE COMMUNICATIONS (2021)
The Roles of the Ubiquitin-Proteasome System in the Endoplasmic Reticulum Stress Pathway
Junyan Qu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
Shuoyi Jiang et al.
CELL DEATH & DISEASE (2021)
The Ubiquitin Proteasome System in Genome Stability and Cancer
Jonathan J. Morgan et al.
CANCERS (2021)
VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines
Nami Kurozumi et al.
CANCER SCIENCE (2021)
USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma
Chi Lv et al.
CELL DEATH & DISEASE (2021)
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
Gabriel LaPlante et al.
CANCERS (2021)
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K. Rowinsky et al.
INVESTIGATIONAL NEW DRUGS (2020)
Response and Resistance to BCR-ABL1-Targeted Therapies
Theodore P. Braun et al.
CANCER CELL (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells
Norihito Shibata et al.
ONCOGENE (2020)
Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
Paola Pellegrini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)
Jieru Zhang et al.
JOURNAL OF CANCER (2020)
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation
Ellin-Kristina Hillert et al.
CANCER LETTERS (2019)
Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options
Daniel Nisakar Meenakshi Sundaram et al.
DRUG DISCOVERY TODAY (2019)
Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma
Yang Yu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinoma
Beibei Sha et al.
APOPTOSIS (2019)
Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma
Liling Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway
Dongyeob Seo et al.
EBIOMEDICINE (2019)
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma
Korbinian N. Kropp et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells
Youming Ding et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
ER stress and cancer: The FOXO forkhead transcription factor link
Glowi Alasiri et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
Xiaohong Xia et al.
ONCOGENESIS (2018)
Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells
Xin Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate
Marco Corazzari et al.
FRONTIERS IN ONCOLOGY (2017)
Proteasome-associated deubiquitinases and cancer
Arjan Mofers et al.
CANCER AND METASTASIS REVIEWS (2017)
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
Xiaoying Lan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Induction of Tumor Cell Apoptosis by a Proteasome Deubiquitinase Inhibitor Is Associated with Oxidative Stress
Slavica Brnjic et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
Ze Tian et al.
BLOOD (2014)
Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation
Xianping Shi et al.
CLINICAL CANCER RESEARCH (2014)
The 19S Deubiquitinase Inhibitor b-AP15 Is Enriched in Cells and Elicits Rapid Commitment to Cell Death
Xin Wang et al.
MOLECULAR PHARMACOLOGY (2014)
Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling
H. Jung et al.
ONCOGENESIS (2013)
Proteasome deubiquitinases as novel targets for cancer therapy
Padraig D'Arcy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes
Emel B. Gencer et al.
ANNALS OF HEMATOLOGY (2011)
Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis
Hanshi Sun et al.
BLOOD (2011)
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
Padraig D'Arcy et al.
NATURE MEDICINE (2011)
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller et al.
NATURE (2009)
Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells
Q-F Li et al.
ONCOGENE (2007)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
Share Paper
